National Health Investors, Inc.

As of June 30, 2026, National Health Investors, Inc. carries a market capitalization of 3.32B, placing it among publicly traded companies globally. Its enterprise value stands at 4.42B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

National Health Investors, Inc.'s next confirmed earnings release is scheduled for November 9, 2026.

As of June 30, 2026, National Health Investors, Inc. has 49.12M shares outstanding.

As of June 30, 2026, National Health Investors, Inc. trades at a trailing price-to-earnings ratio of 22.17. The price-to-sales ratio is 8.56, and the price-to-book ratio stands at 2.41.

As of June 30, 2026, National Health Investors, Inc. trades at an EV/EBITDA multiple of 17.59 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 11.69 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 25.76 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. National Health Investors, Inc. trades at an EV/FCF ratio of 16.62, comparing the total takeover cost of the business to the cash it actually generates for all capital providers. These enterprise value multiples are built on an enterprise value of 4.42B versus a market cap of 3.32B, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, National Health Investors, Inc. maintains a current ratio of 0.72, meaning it holds 0.7x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 80.43, indicating elevated leverage, while an interest coverage ratio of 5.16 demonstrates adequate ability to service its debt obligations.

Over the twelve months ended June 30, 2026, National Health Investors, Inc. posted a return on equity (ROE) of 10.93, showing how much profit the company earns on every dollar of shareholder capital. Return on invested capital (ROIC) comes in at 7.13 - the clearest signal of whether the business earns more on its capital than that capital costs, and the core measure of a durable competitive advantage. Return on assets (ROA) stands at 5.89, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 8.16, useful for judging operating efficiency across full business cycles. The company generates approximately 12.01M in revenue per employee across its workforce of 31.50, a quick read on workforce productivity versus industry peers.

Over the twelve months ended June 30, 2026, National Health Investors, Inc. recorded 640,719.60 in income tax expense. That works out to an effective tax rate of 0.44, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 145.41M, leaving 146.00M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on October 22, 2026, National Health Investors, Inc.'s stock has declined approximately 8.53% over the past 52 weeks. The 50-day moving average sits at 60.00, while the 200-day moving average is 66.06.

Over the twelve months ended June 30, 2026, National Health Investors, Inc. generated 378.23M in revenue and converted that into 146.00M in net income, yielding earnings per share of 3.01. EBITDA reached 251.48M, while operating income came in at 171.73M.

As of June 30, 2026, National Health Investors, Inc. holds 26.60M in cash and equivalents against 1.12B in total debt, resulting in a net debt position of 1.09B. Total book value stands at 1.38B, with working capital of -128.64M providing operational flexibility.

National Health Investors, Inc. produced 217.67M in operating cash flow over the twelve months ended June 30, 2026.

Over the twelve months ended June 30, 2026, National Health Investors, Inc. posted a gross margin of 97.52, reflecting its pricing power and cost economics. The operating margin of 45.40 and net profit margin of 38.60 provide insight into operational efficiency.

Over the twelve months ended June 30, 2026, National Health Investors, Inc. paid dividends of 3.20 per share. The dividend payout ratio of 107.07 exceeds 100%, meaning the company is distributing more than it earns and funding the dividend from cash reserves, asset sales, or borrowing, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Free cash flow yield stands at 6.70, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield is negative at -1.98, meaning National Health Investors, Inc. raised more capital through share issuance and new debt than it returned via dividends and buybacks.

As of June 30, 2026, National Health Investors, Inc. has an Altman Z-Score of 3.30, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.